Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-24-027862
Filing Date
2024-08-27
Accepted
2024-08-27 17:02:49
Documents
6
Effectiveness Date
2024-08-27
Reference 429
333-259585

Document Format Files

Seq Description Document Type Size
1 FORM S-8 pbyi20240826_s8.htm S-8 63524
2 EXHIBIT 5.1 ex_718622.htm EX-5.1 11828
3 EXHIBIT 23.1 ex_718623.htm EX-23.1 3638
4 EXHIBIT FILING FEES ex_718624.htm EX-FILING FEES 15423
5 kpmg01.jpg GRAPHIC 2459
6 lwlogo.jpg GRAPHIC 3495
  Complete submission text file 0001437749-24-027862.txt   104161
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281803 | Film No.: 241249906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)